Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 133

1.

The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers.

Apostolova I, Ego K, Steffen IG, Buchert R, Wertzel H, Achenbach HJ, Riedel S, Schreiber J, Schultz M, Furth C, Derlin T, Amthauer H, Hofheinz F, Kalinski T.

Eur J Nucl Med Mol Imaging. 2016 Jul 28. [Epub ahead of print]

PMID:
27470327
2.

Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system.

Damm R, Seidensticker R, Ulrich G, Breier L, Steffen IG, Seidensticker M, Garlipp B, Mohnike K, Pech M, Amthauer H, Ricke J.

BMC Cancer. 2016 Jul 20;16:509. doi: 10.1186/s12885-016-2549-x.

3.

Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node staging.

Rogasch JM, Apostolova I, Steffen IG, Steinkrüger FL, Genseke P, Riedel S, Wertzel H, Achenbach HJ, Kalinski T, Schultz M, Schreiber J, Amthauer H, Furth C.

Eur J Radiol. 2016 Aug;85(8):1345-50. doi: 10.1016/j.ejrad.2016.05.004. Epub 2016 May 11.

PMID:
27423672
4.

Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET.

Hofheinz F, Hoff Jv, Steffen IG, Lougovski A, Ego K, Amthauer H, Apostolova I.

EJNMMI Res. 2016 Dec;6(1):53. doi: 10.1186/s13550-016-0208-5. Epub 2016 Jun 22.

5.

Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor model.

Seidensticker M, Streit S, Nass N, Wybranski C, Jürgens J, Brauner J, Schulz N, Kalinski T, Seidensticker R, Garlipp B, Steffen I, Ricke J, Dudeck O.

Diagn Interv Radiol. 2016 Jul-Aug;22(4):378-84. doi: 10.5152/dir.2016.15462.

6.

Run-Off Computed Tomography Angiography (CTA) for Discriminating the Underlying Causes of Intermittent Claudication.

Preuß A, Schaafs LA, Werncke T, Steffen IG, Hamm B, Elgeti T.

PLoS One. 2016 Apr 7;11(4):e0152780. doi: 10.1371/journal.pone.0152780. eCollection 2016.

7.

Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.

Prasad V, Steffen IG, Diederichs G, Makowski MR, Wust P, Brenner W.

Mol Imaging Biol. 2016 Jun;18(3):428-36. doi: 10.1007/s11307-016-0945-x.

PMID:
27038316
8.

Correction: A Novel Rhabdovirus Associated with Acute Hemorrhagic Fever in Central Africa.

Grard G, Fair JN, Lee D, Slikas E, Steffen I, Muyembe JJ, Sittler T, Veeraraghavan N, Ruby JG, Wang C, Makuwa M, Mulembakani P, Tesh RB, Mazet J, Rimoin AW, Taylor T, Schneider BS, Simmons G, Delwart E, Wolfe ND, Chiu CY, Leroy EM.

PLoS Pathog. 2016 Mar 18;12(3):e1005503. doi: 10.1371/journal.ppat.1005503. eCollection 2016 Mar. No abstract available.

9.

An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET.

Hofheinz F, Bütof R, Apostolova I, Zöphel K, Steffen IG, Amthauer H, Kotzerke J, Baumann M, van den Hoff J.

EJNMMI Res. 2016 Dec;6(1):19. doi: 10.1186/s13550-016-0174-y. Epub 2016 Mar 2.

10.

Activity-based cost analysis of hepatic tumor ablation using CT-guided high-dose rate brachytherapy or CT-guided radiofrequency ablation in hepatocellular carcinoma.

Schnapauff D, Collettini F, Steffen I, Wieners G, Hamm B, Gebauer B, Maurer MH.

Radiat Oncol. 2016 Feb 25;11:26. doi: 10.1186/s13014-016-0606-x.

11.

Pseudotyping Viral Vectors With Emerging Virus Envelope Proteins.

Steffen I, Simmons G.

Curr Gene Ther. 2016;16(1):47-55.

PMID:
26785737
12.

Significance of a Single-Time-Point Somatostatin Receptor SPECT/Multiphase CT Protocol in the Diagnostic Work-up of Gastroenteropancreatic Neuroendocrine Neoplasms.

Ruf J, von Wedel F, Furth C, Denecke T, Stelter L, Steffen IG, Schütte K, Arend J, Ulrich G, Klose S, Bornschein J, Apostolova I, Amthauer H.

J Nucl Med. 2016 Feb;57(2):180-5. doi: 10.2967/jnumed.115.161117. Epub 2015 Nov 25.

PMID:
26609177
13.

Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients.

Rogasch JM, Steffen IG, Riedel S, Apostolova I, Wertzel H, Achenbach HJ, Steinkrüger FL, Kalinski T, Schultz M, Schreiber J, Amthauer H, Furth C.

Eur Radiol. 2016 Aug;26(8):2808-18. doi: 10.1007/s00330-015-4093-5. Epub 2015 Nov 11.

PMID:
26560731
14.

The influence of different signal-to-background ratios on spatial resolution and F18-FDG-PET quantification using point spread function and time-of-flight reconstruction.

Rogasch JM, Hofheinz F, Lougovski A, Furth C, Ruf J, Großer OS, Mohnike K, Hass P, Walke M, Amthauer H, Steffen IG.

EJNMMI Phys. 2014 Dec;1(1):12. doi: 10.1186/2197-7364-1-12. Epub 2014 Sep 19.

PMID:
26501454
15.

Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids.

Prasad V, Steffen IG, Pavel M, Denecke T, Tischer E, Apostolopoulou K, Pascher A, Arsenic R, Brenner W.

EJNMMI Res. 2015 Dec;5(1):53. doi: 10.1186/s13550-015-0130-2. Epub 2015 Oct 12.

16.

Optimization of SPECT-CT Hybrid Imaging Using Iterative Image Reconstruction for Low-Dose CT: A Phantom Study.

Grosser OS, Kupitz D, Ruf J, Czuczwara D, Steffen IG, Furth C, Thormann M, Loewenthal D, Ricke J, Amthauer H.

PLoS One. 2015 Sep 21;10(9):e0138658. doi: 10.1371/journal.pone.0138658. eCollection 2015.

17.

Time-Resolved Analysis of Left Ventricular Shear Wave Amplitudes in Cardiac Elastography for the Diagnosis of Diastolic Dysfunction.

Elgeti T, Steffen IG, Knebel F, Hättasch R, Hamm B, Braun J, Sack I.

Invest Radiol. 2016 Jan;51(1):1-6. doi: 10.1097/RLI.0000000000000198.

PMID:
26309183
18.

Optimizing scintigraphic evaluation of split renal function in living kidney donors using the geometric mean method: a preliminary retrospective study.

Weinberger S, Baeder M, Scheurig-Muenkler C, Steffen IG, Magheli A, Miller K, Kempkensteffen C.

J Nephrol. 2016 Jun;29(3):435-41. doi: 10.1007/s40620-015-0223-z. Epub 2015 Aug 19.

PMID:
26286903
19.

Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study).

Seidensticker M, Garlipp B, Scholz S, Mohnike K, Popp F, Steffen I, Seidensticker R, Stübs P, Pech M, PowerskI M, Hass P, Costa SD, Amthauer H, Bruns C, Ricke J.

BMC Cancer. 2015 Jul 14;15:517. doi: 10.1186/s12885-015-1499-z.

20.

The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases.

Rogasch JM, Steffen IG, Hofheinz F, Großer OS, Furth C, Mohnike K, Hass P, Walke M, Apostolova I, Amthauer H.

EJNMMI Res. 2015 May 6;5:31. doi: 10.1186/s13550-015-0111-5. eCollection 2015.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk